{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:27:00Z","timestamp":1782368820745,"version":"3.54.5"},"reference-count":25,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,7,19]],"date-time":"2008-07-19T00:00:00Z","timestamp":1216425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Polyamines (putrescine, spermidine and spermine) are essential for cell growth and differentiation. Nitric oxide exhibits antihypertrophic functions and inhibits cardiac remodelling. However, the metabolism of polyamines and the potential interactions with nitric oxide in cardiac hypertrophy remain unclear. We randomly divided Wistar rats into four treatment groups: controls, isoproterenol (ISO), ISO and <jats:sc>l<\/jats:sc>\u2010arginine, and <jats:sc>l<\/jats:sc>\u2010arginine. Isoproterenol (5\u00a0mg\/kg\/day, subcutaneously) and\/or <jats:sc>l<\/jats:sc>\u2010arginine (800\u00a0mg\/kg\/day, intraperitoneally) was administered once daily for 7 days. The expression of atrial natriuretic peptide mRNA was determined by reverse transcription\u2013polymerase chain reaction, and fibrogenesis of heart was assessed by Van Gieson staining. Polyamines were measured with high\u2010performance liquid chromatography, and plasma nitric oxide content and lactate dehydrogenase (LDH) activity were determined with a spectrophotometer. The expression levels of ornithine decarboxylase, spermidine\/spermine N1\u2010acetyltransferase (SSAT), endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) were analysed by Western blot. Heart\u2010to\u2010body weight ratio, left ventricle\u2010to\u2010body weight ratio, atrial natriuretic peptide mRNA expression, collagen fibres and LDH activity were elevated, both ornithine decarboxylase and SSAT proteins were up\u2010regulated, and total polyamines were increased in the group treated with ISO. Additionally, the expression of iNOS was up\u2010regulated, eNOS was down\u2010regulated, and nitric oxide levels were low. Notably, cotreatment with <jats:sc>l<\/jats:sc>\u2010arginine reversed most of these changes except for SSAT expression, which was further up\u2010regulated. We propose that increased polyamines and decreased nitric oxide are involved in cardiac hypertrophy induced by ISO and suggest that <jats:sc>l<\/jats:sc>\u2010arginine pre\u2010treatment can attenuate cardiac hypertrophy through the regulation of key enzymes of the polyamine and nitric oxide pathways.<\/jats:p>","DOI":"10.1111\/j.1742-7843.2008.00261.x","type":"journal-article","created":{"date-parts":[[2008,7,19]],"date-time":"2008-07-19T18:34:25Z","timestamp":1216492465000},"page":"124-130","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["<scp>l<\/scp>\u2010Arginine Inhibits Isoproterenol\u2010Induced Cardiac Hypertrophy through Nitric Oxide and Polyamine Pathways"],"prefix":"10.1111","volume":"103","author":[{"given":"Yan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li\u2010Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu\u2010Hui","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong\u2010Zhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng\u2010Gang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya\u2010Jun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao\u2010Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang\u2010Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,19]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000038488.38975.1A"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.100127897"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000137831.08683.E1"},{"key":"e_1_2_6_5_2","first-page":"14","article-title":"l\u2010Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor","volume":"10","author":"B\u00f6ger RH","year":"2005","journal-title":"Altern Med Rev"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.66.851"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-004-0078-4"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.071054698"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd794"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-006-0273-6"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.2001.0865"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_569.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2007.00006.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2007.01.096"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2005.pto960107.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-6363(96)88546-4"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641969709080819"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj3580025"},{"key":"e_1_2_6_19_2","first-page":"14445","article-title":"Inhibition of viral replication by interferon\u2010gamma\u2010induced nitric oxide synthase","volume":"26","author":"Karupiah G","year":"1993","journal-title":"Science"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.13.6954"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.23.6.1121"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000100445.80029.8E"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00851.2003"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe048269"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2007.00147.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.25.779"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-7843.2008.00261.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-7843.2008.00261.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T17:57:41Z","timestamp":1697047061000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-7843.2008.00261.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,19]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1742-7843.2008.00261.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-7843.2008.00261.x","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,19]]},"assertion":[{"value":"2008-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}